Biogen Inc. (ETR:IDP)
Germany · Delayed Price · Currency is EUR 126.10
-3.45 (-2.66%)
Oct 10, 2025, 5:35 PM CET
Biogen Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| 9,864 | 9,676 | 9,836 | 10,173 | 10,982 | 13,445 | Upgrade | |
Revenue Growth (YoY) | 2.14% | -1.62% | -3.32% | -7.36% | -18.32% | -6.49% | Upgrade |
Cost of Revenue | 2,457 | 2,310 | 2,533 | 2,278 | 2,110 | 1,805 | Upgrade |
Gross Profit | 7,407 | 7,366 | 7,302 | 7,895 | 8,872 | 11,639 | Upgrade |
Selling, General & Admin | 2,425 | 2,404 | 2,550 | 2,404 | 2,674 | 2,505 | Upgrade |
Depreciation & Amortization Expenses | 524.2 | 446.7 | 240.6 | 365.9 | 881.3 | 464.8 | Upgrade |
Research & Development | 1,924 | 2,042 | 2,462 | 2,231 | 2,519 | 4,066 | Upgrade |
Other Operating Expenses | 356.7 | 223.7 | 437.6 | -589.1 | -43.5 | 54.1 | Upgrade |
Operating Income | 2,178 | 2,250 | 1,612 | 3,484 | 2,841 | 4,550 | Upgrade |
Other Non-Operating Income (Expense) | - | 343.6 | 315.5 | -108.2 | 0 | -497.4 | Upgrade |
Total Non-Operating Income (Expense) | - | 343.6 | 315.5 | -108.2 | - | -497.4 | Upgrade |
Pretax Income | 1,798 | 1,906 | 1,297 | 3,592 | 1,745 | 5,048 | Upgrade |
Provision for Income Taxes | 267.2 | 273.8 | 135.3 | 632.8 | 52.5 | 992.3 | Upgrade |
Net Income | 1,531 | 1,632 | 1,161 | 3,050 | 1,591 | 4,006 | Upgrade |
Minority Interest in Earnings | - | - | 0.4 | -87.9 | 136.6 | 54.6 | Upgrade |
Net Income to Common | 1,531 | 1,632 | 1,161 | 3,050 | 1,591 | 4,006 | Upgrade |
Net Income Growth | 32.21% | 40.57% | -61.92% | 91.67% | -60.28% | -31.04% | Upgrade |
Shares Outstanding (Basic) | 146 | 146 | 145 | 145 | 149 | 161 | Upgrade |
Shares Outstanding (Diluted) | 146 | 146 | 146 | 146 | 150 | 161 | Upgrade |
Shares Change (YoY) | 0.45% | 0.21% | -0.27% | -2.41% | -7.25% | -13.93% | Upgrade |
EPS (Basic) | 10.47 | 11.21 | 8.02 | 20.96 | 10.44 | 24.86 | Upgrade |
EPS (Diluted) | 10.45 | 11.18 | 7.97 | 20.87 | 10.40 | 24.80 | Upgrade |
EPS Growth | 31.61% | 40.28% | -61.81% | 100.67% | -58.06% | -21.07% | Upgrade |
Free Cash Flow | 1,979 | 2,722 | 1,270 | 1,144 | 3,382 | 3,805 | Upgrade |
Free Cash Flow Growth | -27.30% | 114.28% | 11.03% | -66.17% | -11.12% | -42.03% | Upgrade |
Free Cash Flow Per Share | 13.53 | 18.66 | 8.72 | 7.84 | 22.61 | 23.59 | Upgrade |
Gross Margin | 75.10% | 76.12% | 74.24% | 77.61% | 80.79% | 86.57% | Upgrade |
Operating Margin | 22.08% | 23.25% | 16.39% | 34.24% | 25.87% | 33.84% | Upgrade |
Profit Margin | 15.52% | 16.87% | 11.81% | 29.11% | 15.73% | 30.20% | Upgrade |
FCF Margin | 20.06% | 28.13% | 12.91% | 11.25% | 30.79% | 28.30% | Upgrade |
EBITDA | 2,922 | 2,923 | 2,107 | 4,002 | 3,328 | 5,007 | Upgrade |
EBITDA Margin | 29.62% | 30.21% | 21.42% | 39.34% | 30.31% | 37.24% | Upgrade |
EBIT | 2,178 | 2,250 | 1,612 | 3,484 | 2,841 | 4,550 | Upgrade |
EBIT Margin | 22.08% | 23.25% | 16.39% | 34.24% | 25.87% | 33.84% | Upgrade |
Effective Tax Rate | 14.86% | 14.37% | 10.43% | 17.62% | 3.01% | 19.66% | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.